US Corporate Distress Financial Stress SEC Filings — June 17, 2026

17-06-2026

Dorman Products, Inc. entered into Amendment No. 3 to its Credit Agreement, effective June 16, 2026, which, among other changes, extends the maturity of the Revolving Credit Commitments and increases the aggregate Revolving Credit Commitments. The amendment is conditioned on the issuance of $450 million in 2034 Senior Notes, the proceeds of which will be used to prepay all outstanding Amendment No. 1 Term Loans and related fees and expenses. The amendment also involves the addition of new lenders and the departure of certain existing lenders.

• · The amendment involves the reallocation of Revolving Credit Loans and participations in Letters of Credit among Consenting Lenders, New Lenders, Increased Lenders, Decreased Lenders, and Departing Lenders.
• · The amendment also amends and restates several schedules and exhibits to the Original Credit Agreement, including Schedules 7.2, 7.18, 7.19, 8.12, 8.21, 9.1, 9.2, and 9.3.
• · The amendment adds new Exhibits J and K to the Credit Agreement.
• · The amendment is subject to the satisfaction of conditions including delivery of closing certificates, certificates of good standing, legal opinions, a solvency certificate, and compliance with PATRIOT Act and Beneficial Ownership Regulation requirements.

17-06-2026

Antero Resources Corporation has entered into a commercial paper dealer agreement under a 4(a)(2) program, dated June 16, 2026, to issue short-term promissory notes (Notes) with maturities not exceeding 397 days and a minimum face amount of $250,000. The program allows for sales to qualified institutional buyers and institutional accredited investors, with no obligation on either party to sell or purchase Notes. The filing does not disclose the maximum aggregate amount of the program or any specific financial terms, but establishes the framework for future note issuances.

• · The Notes are issued under an Issuing and Paying Agency Agreement dated June 16, 2026.
• · Notes may be issued as individual physical certificates or book-entry notes registered in the name of DTC.
• · The Issuer represents it is not currently issuing commercial paper under Section 3(a)(3) of the Securities Act and will segregate proceeds if it does so.
• · The Issuer agrees to omit the Dealer's name from public filings and redact identifying information.
• · No sale to any one purchaser shall be for less than $250,000 face amount.
• · The program is structured to rely on the Section 4(a)(2) exemption from registration under the Securities Act.

17-06-2026

Dyne Therapeutics expanded its debt facility with Hercules Capital to up to $400.0 million by adding two additional tranches of $50.0 million each and increasing the final tranche by $25.0 million. The company borrowed $50.0 million on the closing date, bringing outstanding principal to $200.0 million, with up to $125.0 million available upon achieving clinical, regulatory, and commercial milestones and a discretionary $75.0 million tranche. The amendment also reduced the minimum cash covenant from 60% to 40% of outstanding obligations and pushed the initial testing date to July 1, 2027 (extendable to July 1, 2028), while the covenant is only tested if market capitalization falls below $1.65 billion.

• · Interest-only period runs until July 1, 2029, extendable to Maturity Date (July 1, 2030) upon achieving specified milestones.
• · Interest rate is floating at Wall Street Journal prime rate plus 2.45%, with a floor of 7.50%.
• · The company granted a first-priority security interest in substantially all property, including intellectual property.
• · The minimum cash covenant initial testing date was moved from January 1, 2027 to July 1, 2027, extendable to July 1, 2028 if financing milestones are met.
• · The cash covenant is only tested if market capitalization is less than $1.65 billion.

17-06-2026

N-able, Inc. entered into a Third Amendment to its Credit Agreement on June 16, 2026, adding a $75.0 million delayed draw term loan facility. The facility is available for borrowing over a six-month period and will be used for general corporate purposes, including funding deferred consideration from the November 2024 acquisition of Adlumin, Inc., future acquisitions, share repurchases, and fees. The loans bear interest at a floating SOFR-based rate plus a margin initially set at 2.75%, which can decrease to 2.50% if the company's first lien net leverage ratio is 1.65 to 1.00 or lower.

• · The Delayed Draw Term Loans are fungible with the existing term loan facility and share the same maturity date, interest rates, and other material terms.
• · The facility was added via a Third Amendment to the Credit Agreement dated July 19, 2021.
• · Proceeds may be used for general corporate purposes, including funding deferred consideration from the November 2024 acquisition of Adlumin, Inc., future permitted acquisitions, share repurchases, and related fees and expenses.
• · The interest rate is a floating SOFR-based rate with a 0.0% floor, plus a margin initially set at 2.75%, subject to a decrease to 2.50% if the first lien net leverage ratio is ≤ 1.65x.

17-06-2026

XCF Global, Inc. terminated a Purchase Agreement with Helena Global Investment Opportunities I LTD. on June 15, 2026, which had allowed the company to sell up to $50,000,000 of its Common Stock. The termination releases approximately 55,000,000 shares previously reserved for issuance, reducing potential dilution and market overhang, but also removes a committed equity financing facility, leaving the company without that source of capital.

• · The Purchase Agreement was dated May 30, 2025, and terminated on June 15, 2026.
• · The purchase price for shares under the Agreement was based on the lowest intraday sale price during the three trading days after Helena's receipt of the Common Shares.
• · The termination reduces potential shorting activity by market participants associated with the market overhang.
• · The company retains flexibility to pursue other financing alternatives.

17-06-2026

Apyx Medical Corp entered into a letter agreement with Chairman Stavros Vizirgianakis on June 11, 2026, appointing him as Executive Chairman. In connection with the appointment, the Board granted him 450,000 restricted stock units (RSUs) under the 2023 Share Incentive Plan, with one-third vesting immediately and the remainder vesting over the next two years. Mr. Vizirgianakis will provide strategic leadership and governance oversight but will not serve as an officer or employee.

• · The RSUs are granted under the Company's 2023 Share Incentive Plan.
• · Each RSU represents a contingent right to receive one share of common stock.
• · Vesting is subject to continued service through applicable vesting dates.
• · Mr. Vizirgianakis will not be designated as an 'executive officer' under Rule 3b-7.

17-06-2026

ISQ Open Infrastructure Company LLC – Series II, a registered series of ISQ Open Infrastructure Company LLC, entered into a credit agreement dated June 11, 2026, with Sumitomo Mitsui Banking Corporation (SMBC) as Administrative Agent and Lead Arranger, along with other lenders. The facility provides loans to finance the borrowers' investment activities and working capital, with commitments and advance rates defined in the agreement. No specific monetary amounts, interest rates, or financial covenants are disclosed in this excerpt, and no prior-period comparisons are available.

• · The credit agreement was entered into on June 11, 2026 (Closing Date).
• · The Initial Primary Borrower is ISQ Open Infrastructure Company LLC – Series II, a registered series under Delaware law.
• · The facility is intended to finance investment activities and provide working capital.
• · The Administrative Agent and Lead Arranger is Sumitomo Mitsui Banking Corporation (SMBC).
• · The agreement includes provisions for additional primary borrowers, qualified borrowers, and extension of maturity date.
• · The Availability Period runs from the Closing Date to the earliest of 30 days prior to the Maturity Date, termination of commitments, or an event of default.
• · The agreement specifies an Account Bank (initially Bank of New York Mellon or JPMorgan Chase) and an Approved Valuation Agent (e.g., Big Four firms or Kroll).
• · The Advisor is ISQ OpenInfra Registered Advisor LLC.

17-06-2026

Lesaka Technologies, Inc. filed an 8-K on June 17, 2026, disclosing that its subsidiary, Lesaka Technologies Proprietary Limited, agreed to extend the long-stop date of the Transaction Implementation Agreement with Zero Research Proprietary Limited and Bank Zero Mutual Bank from August 6, 2026, to January 31, 2027, while awaiting outstanding regulatory consents. The extension indicates ongoing regulatory delays but keeps the transaction alive.

• · The Transaction Implementation Agreement was originally entered into on June 26, 2025.
• · The extension was agreed upon on June 11, 2026.
• · The new long-stop date is January 31, 2027.
• · The agreement involves all shareholders of Bank Zero (except Zero Research and Naught Holdings Ltd) and all shareholders of Zero Research (except Naught Holdings Ltd).

17-06-2026

Workhorse Group Inc. entered into Omnibus Amendment No. 2 with its lender, Motive GM Holdings II LLC, to restructure its credit facilities. The amendment increases the cash flow credit commitment by $10M (from $20M to $30M) while decreasing the customer order credit commitment by $10M (from $30M to $20M), resulting in a net unchanged total borrowing capacity of $50M. As consideration, Workhorse must issue equity warrants to the lender within 45 days, and interest on a $10M loan drawn at the amendment date is deferred until after September 30, 2026. However, lenders have no binding commitment to make loans under the cash flow facility after the PIPE closing date, and the change signals a shift in liquidity toward general working capital needs rather than customer-order-specific financing.

• · The lender has no binding commitment to make loans under the cash flow credit agreement after the PIPE closing date; loans become discretionary.
• · Interest on the $10M loan made on the amendment date is deferred—first payment due after September 30, 2026.
• · Guarantors include 11 subsidiaries, all of which reaffirmed their obligations under the amended credit agreements.
• · The security agreement continues in full force with a perfected first-priority lien on collateral in favor of the collateral agent.

17-06-2026

Outset Medical, Inc. entered into a Refresh Amendment to its Purchasing Agreement with HCA Management Services, L.P., committing HCA to purchase new Tablo Hemodialysis Systems from 2026 through 2028 with an aggregate contract value of approximately $40 million. The company reiterated its previously issued 2026 guidance and plans to provide additional financial impact details later in the year. No negative or flat performance metrics were disclosed in this filing.

• · The Amendment was entered into on June 14, 2026, and filed on June 17, 2026.
• · The original Purchasing Agreement was dated May 1, 2020.
• · The Amendment provides a console and consumables purchase framework to support potential future growth beyond HCA hospitals that have already adopted the hemodialysis in-sourcing model with Tablo.
• · The company reiterated its previously issued 2026 guidance and will provide additional detail on the financial impact of the Amendment later in the year.

17-06-2026

Gencor Industries disclosed it received a delinquency notice from NYSE Regulation on May 19, 2026, for failure to file its Form 10-Q for the period ended March 31, 2026, by the extended deadline of May 18, 2026, triggering potential delisting proceedings under Section 1007 of the NYSE American Company Guide. The company subsequently filed the Form 10-Q on June 12, 2026, within the initial six-month cure period, and received confirmation from NYSE on June 15, 2026, that it has regained compliance and been removed from the late filers' list.

• · The initial delinquency notice was received on May 19, 2026, for failure to file the March 31, 2026 Form 10-Q by the May 18, 2026 extended deadline.
• · The company had six months from May 18, 2026 to regain compliance; it filed the Form 10-Q on June 12, 2026.
• · NYSE expressly reserved the right to commence suspension/delisting proceedings at any time if circumstances warrant, even during the cure period.
• · Compliance was formally confirmed on June 15, 2026, and the company was removed from the late filers' list.

17-06-2026

Simulations Plus, Inc. has entered into a definitive Agreement and Plan of Merger with SP Evolution HoldCo II, LLC and its subsidiary SP Evolution BidCo II, LLC, dated June 15, 2026, whereby Merger Sub will merge with and into Simulations Plus. The board of directors unanimously approved the merger as fair and in the best interests of shareholders and recommended adoption by shareholders. The agreement includes a voting and support agreement with Dr. Walter Woltosz and limited guarantees and equity commitments from the Guarantors identified in Exhibit A, but the filing does not disclose the per-share consideration or aggregate deal value.

• · The merger agreement was unanimously approved by Simulations Plus's board of directors.
• · Dr. Walter Woltosz has entered into a voting and support agreement with Parent and Merger Sub.
• · The merger will be submitted to a vote at a meeting of the company's shareholders.
• · The Guarantors have provided a Limited Guarantee and an Equity Commitment Letter to support Parent's and Merger Sub's obligations.
• · The Company has a 2021 Equity Incentive Plan (Company Equity Plan) referenced in the agreement.
• · The agreement includes a 'Company Material Adverse Effect' definition with standard exclusions for industry and macroeconomic changes.

17-06-2026

On June 15, 2026, Greenland Mines Ltd. (formerly Klotho Neurosciences, Inc., ticker GRML) entered into a Securities Purchase Agreement with three investors to issue and sell 15,000,000 shares of common stock for total gross proceeds of $3,750,000. The capital raise (approximately $0.25 per share) will be used for working capital and general corporate purposes, with closing expected on or before June 25, 2026. No balance sheet, income statement, or cash flow data is included in the filing, so there are no period-over-period comparisons available.

• · The offering is being conducted under Section 4(2) of the Securities Act and Rule 506 of Regulation D (private placement).
• · The filing includes the required cover page interactive data file (Inline XBRL).
• · The company is classified as an emerging growth company and trades under symbols GRML (common stock) and GRMLW (warrants) on Nasdaq.
• · No underwriting fees or discounts are disclosed in the filing.
• · The agreement was executed on June 15, 2026, and the report was filed on June 17, 2026.

17-06-2026

Enterprise Financial Services Corp completed a $175.0M offering of 6.25% Fixed-to-Floating Rate Subordinated Notes due 2036, generating net proceeds of approximately $172.8M. The Company intends to use the proceeds for general corporate purposes including debt repayment, dividends, organic growth, acquisitions, and regulatory capital support for its subsidiary. The notes carry an initial fixed rate of 6.25% through June 30, 2031, then float at Three-Month Term SOFR plus 232 bps, and are subordinated to senior indebtedness without any sinking fund.

• · The notes were issued under a Subordinated Indenture with U.S. Bank Trust Company, National Association as trustee.
• · Interest on the notes is payable semi-annually from issuance through June 30, 2031, then quarterly from July 1, 2031.
• · The Company may redeem the notes on or after July 1, 2031 at 100% of principal plus accrued interest.
• · Redemption may also occur in whole upon a Tax Event, Tier 2 Capital Event, or investment company registration requirement.
• · The notes are structurally subordinated to all subsidiary obligations, including deposit liabilities and other claims of Enterprise Bank & Trust.
• · The offering was made under an existing S-3 shelf registration statement (File No. 333-294014) filed March 4, 2026.

17-06-2026

AXT INC filed an 8-K on June 17, 2026, reporting a material definitive agreement (Item 1.01) and providing related financial statements and exhibits (Item 9.01). The filing does not disclose the counterparty, dollar value, or specific terms of the agreement, limiting the ability to assess financial impact. No other items (e.g., Item 2.01, 5.02) were reported, and no negative or flat metrics were mentioned.

• · Filing size: 162 KB, indicating moderate detail but no quantitative data extracted.
• · AccNo: 0001437749-26-020978, suggesting standard SEC filing sequence.
• · No exhibits or financial statements were described in the summary; actual exhibits may contain material terms.

17-06-2026

QXO, Inc. filed a Form 8-K on June 17, 2026, reporting a material definitive agreement (Item 1.01), the creation of a direct financial obligation (Item 2.03), and other events (Item 8.01). The filing fails to disclose the specific transaction details, dollar value, counterparty, or financial impacts. While the listing of these items suggests a significant financing or acquisition event, the lack of quantitative data severely limits any definitive investment thesis. The filing is neutral on its face, requiring urgent follow-up disclosures. There are no positive or negative performance metrics reported in this filing—only the occurrence of a material event whose size and nature are unknown.

• · Filing date: June 17, 2026 (on-time within 4 business days of event).
• · Multi-item filing: Items 1.01, 2.03, 8.01, and 9.01 (exhibits).
• · No exhibits or financial statements were included in the summary text.
• · Sector not specified.

17-06-2026

iQSTEL Inc. filed an amended and restated Certificate of Designation for its Series B Preferred Stock on June 17, 2026. The amendment, approved by a majority stockholder vote, establishes 200,000 shares of Series B Preferred Stock with a liquidation preference of $81 per share plus accrued dividends, a 24% annual dividend rate, conversion rights at 12.5 common shares per preferred share, and a mandatory one-year leak-out agreement limiting conversion sales to 5% of monthly liquidity. The filing modifies existing terms after issuance, creating a significant new capital structure with high-cost dividend obligations.

• · Series B Preferred Stock has no voting rights except as required by law.
• · Conversion rate is 12.5 common shares for each Series B Preferred share, subject to anti-dilution adjustments.
• · Dividends are cumulative and accrue from issuance date, payable in kind only when declared by the board.
• · No dividends can be paid on junior securities (common stock or Series A preferred) while Series B is outstanding.
• · A Change in Control Event (e.g., sale of >50% voting power) is not treated as a liquidation event under the designation.
• · Holders must provide 5 days' notice before converting; no fractional shares are issued, rounding up instead.
• · The issuer must reserve sufficient authorized common shares to cover conversion of all outstanding Series B shares.

17-06-2026

Kilroy Realty, L.P. closed on a fifth amended and restated senior unsecured revolving credit facility increasing borrowing capacity to $1.25B (from $1.10B) with extended maturity to July 31, 2030, and an amended term loan facility of $250M (from $200M) maturing July 31, 2031. The recast improved pricing by reducing SOFR borrowing spreads by 10 bps on both facilities and eliminating the 10 bps SOFR credit spread adjustment, while extending maturities by two years on the revolver and nearly five years on the term loan. However, the company's stabilized portfolio occupancy was 77.6% and leased at 82.3% as of March 31, 2026, indicating continued softness in office and life science space demand.

• · The Revolving Credit Facility includes two 6-month extension options.
• · The Term Loan Facility has no extension options.
• · The $50M additional delayed draw term loan commitments are available to be drawn through June 11, 2027.
• · Annual facility fee on the Revolving Credit Facility remains unchanged at 25 bps.
• · Kilroy Realty Corporation is a publicly traded REIT and member of the S&P MidCap 400 Index.
• · The company has operations in San Francisco Bay Area, Los Angeles, Seattle, San Diego, and Austin.
• · As of March 31, 2026, the stabilized portfolio totaled approximately 17.1 million square feet of primarily office and life science space.

17-06-2026

Vestand Inc. (VSTD) received a Nasdaq letter on June 12, 2026, stating it failed to regain compliance with the $1.00 minimum bid price requirement by the June 10, 2026 deadline and is not eligible for an additional compliance period. The deficiency will now be considered by the Nasdaq Hearings Panel alongside a prior delisting determination for missing periodic SEC filings. The company has requested a hearing and a stay of suspension, which was granted, but there is no assurance that continued listing will be granted.

• · The initial 180-day compliance period ended June 10, 2026.
• · The company is also non-compliant with periodic reporting requirements (missed quarterly report for period ended September 30, 2025, annual report for fiscal year ended December 31, 2025, and quarterly report for period ended March 31, 2026).
• · A prior Staff Delisting Determination was issued on or before May 26, 2026.
• · The company's request for a stay of suspension pending the Panel's final determination was granted by Nasdaq.
• · Trading symbol: VSTD on Nasdaq Capital Market.
• · The company was formerly known as Yoshiharu Global Co.

17-06-2026

PIMCO Asset-Based Lending Company LLC filed a Certificate of Cancellation for its Series I registered series, effective immediately as of May 22, 2026. The Series I certificate had been filed on March 11, 2025, indicating that the series existed for approximately 14 months before cancellation. No financial figures or operational details were disclosed in the filing.

• · Series I was originally registered on March 11, 2025, and its certificate of cancellation was filed on May 22, 2026.
• · The cancellation is effective upon filing with the Delaware Secretary of State.
• · The filing was signed by Jason Mandinach, Principal Executive Officer.
• · The cancellation is pursuant to Section 18-218 of the Delaware Limited Liability Company Act.

17-06-2026

DLH Holdings Corp. entered into a Second Amendment to its Second Amended and Restated Credit Agreement, dated June 11, 2026, with First National Bank of Pennsylvania as Administrative Agent and a syndicate of lenders. The amendment reduces the term loan principal from $142.5M to $122M and modifies certain terms, while reaffirming existing security interests and obligations. Lenders received a fee of 0.05% of their total commitments for agreeing to the amendment.

• · The amendment reduces the term loan principal from $142.5M to $122M, a decrease of $20.5M.
• · The amendment was entered into on June 11, 2026, and filed on June 17, 2026.
• · The credit agreement was originally dated December 8, 2022, and previously amended on November 6, 2024.
• · The amendment reaffirms all existing security interests and obligations under the loan documents.
• · No Event of Default or Potential Default existed as of the amendment effective date.
• · The amendment is governed by the laws of the State of Maryland.

17-06-2026

AIxCrypto Holdings, Inc. (AIXC) entered into a common shares purchase agreement with Gold King Arthur Holding Limited for up to $50,000,000 in a private placement, issuing shares at 93% of the lowest VWAP over three days. The company paid a $100,000 upfront fee and will pay a 3.0% draw fee per purchase, while the agreement includes termination triggers such as a 24-month term and potential shareholder approval requirements for issuances above the Exchange Cap.

• · The Exchange Cap is set at 19.99% of voting power of Common Shares outstanding immediately prior to execution of the Purchase Agreement.
• · The Company may deliver VWAP Purchase Notices at its sole discretion during the investment period, subject to conditions.
• · The Purchase Agreement terminates automatically on the earliest of: 24-month anniversary of Initial Registration Statement effectiveness, full purchase of Total Commitment, delisting, 30th trading day after bankruptcy commencement, or appointment of a custodian.
• · The Company may also terminate the agreement after commencement with ten Trading Days' prior written notice.
• · The Purchaser can terminate upon a Fundamental Transaction, material breach by Company (with 15 Trading Day cure), Registration Statement lapse over 45 consecutive or 90 total Trading Days in 365 days, trading suspension over 5 consecutive Trading Days, or other material breaches.
• · The offering is exempt from registration under Section 4(a)(2) of the Securities Act and/or Rule 506(b) of Regulation D.

17-06-2026

Allurion Technologies, Inc. filed an 8-K on June 17, 2026, announcing a 1-for-15 reverse stock split of its common stock, effective at 12:01 a.m. Eastern time on June 18, 2026. The filing also includes a Certificate of Correction to fix a scrivener's error in the original amendment, correcting the effective date from June 17 to June 18, 2026. The reverse stock split will reduce the number of outstanding shares but does not change the authorized share count.

• · The reverse stock split is effective at 12:01 a.m. Eastern time on June 18, 2026 (corrected from June 17).
• · The split applies to all issued and outstanding common stock (including treasury shares) on a stockholder-by-stockholder basis.
• · Fractional shares will be rounded up to a whole share; no fractional shares will be issued.
• · The authorized share count remains unchanged; only the outstanding share count is reduced.
• · The filing includes a Certificate of Correction to correct a scrivener's error in the original effective date.

17-06-2026

Medalist Diversified REIT, Inc. (MDRR) filed an 8-K on June 17, 2026, announcing amendments to its charter to adopt new restrictions on share transfers and ownership aimed at preserving tax benefits under Section 382 of the Internal Revenue Code. The amendments replace existing ownership limits with a new framework that restricts transfers that would cause a person to become a 4.9% shareholder or increase the ownership of existing 4.9% shareholders or exempt persons, with such transfers being void ab initio. The filing does not include any financial performance data.

• · The amendment defines a '4.9-Percent Shareholder' as a person identified as a 5-percent shareholder under Treasury Regulation Section 1.382-2T(g)(1), but with a 4.9% threshold.
• · A 'Restriction Release Date' is defined as the date when Section 382 is repealed, no tax benefits can be carried forward, or the board determines that the limitation is no longer material.
• · The new Article VI prohibits any transfer that would cause a non-4.9% shareholder to become a 4.9% shareholder, or increase the ownership of an existing 4.9% shareholder or exempt person, unless approved by the board.
• · The board may authorize acquisitions in its sole discretion and may require representations or an opinion of counsel that the transfer will not result in limitations under Section 382.
• · Excess shares from prohibited transfers are void ab initio, and the purported transferee is not recognized as a stockholder for any purpose, including voting or receiving dividends.

17-06-2026

On June 12 and June 15, 2026, NovaBay Pharmaceuticals (now Stablecoin Development Corporation) agreed with two investors, R01 Fund LP and Framework Ventures IV L.P., to amend pre-funded warrants issued in October 2025 by removing exercise restrictions. Both investors exercised their warrants on a cashless basis, receiving an aggregate of 22,614,600 shares of common stock after withholding 24,720 shares as the cashless exercise price. Following this issuance, as of June 15, 2026, total outstanding shares increased to 50,449,780.

• · The warrant amendments removed restrictions on exercisability for the October 2025 Pre-Funded Warrants.
• · The warrants were exercised on a cashless basis, meaning no cash proceeds were received by the company.
• · The total number of shares outstanding increased significantly from an undisclosed pre-exercise count to 50,449,780 shares.
• · The company has changed its name from NovaBay Pharmaceuticals to Stablecoin Development Corporation and its ticker symbol is now SDEV on NYSE American.

17-06-2026

Duos Technologies Group, Inc. (Nasdaq: DUOT) closed a $55 million registered direct offering consisting of 2,000,000 shares of common stock and 3,800,000 pre-funded warrants at $9.50 per share/warrant, with proceeds earmarked to expand its Edge Data Center business, working capital, and general corporate purposes. The offering, completed with a single large institutional investor, positions the company for growth but also dilutes existing shareholders. There are no specific declines or flat metrics reported in this capital raise announcement.

• · The offering was made under a shelf registration statement on Form S-3 (File No. 333-293372) filed on February 11, 2026, and declared effective on February 12, 2026.
• · TD Cowen acted as lead bookrunner, Cantor as joint bookrunner.
• · The company describes its focus on providing modular data center colocation and infrastructure, serving both AI and enterprise computing needs.

17-06-2026

South Plains Financial, Inc. (SPFI) entered into a Retirement and Consultancy Agreement with Chairman Curtis C. Griffith, effective June 17, 2026, under which his employment will terminate on December 31, 2026, and he will transition to a consultancy role through at least December 31, 2028. The agreement includes a $50,000 annual Chairman fee, $20,000 board director fee, $42,500 bank director fee, a monthly consultancy fee of $11,458.34, and an annual restricted stock unit grant of $125,000. Additionally, the company will repurchase 300,000 shares of common stock from Griffith by June 30, 2026. However, no new compensatory equity grants will be awarded to Griffith during the transition period, and he will lose all employee benefits after the Employment Termination Date.

• · Mr. Griffith's employment terminates on December 31, 2026, and he will continue as Chairman of the Company Board and as a Bank director after that date.
• · The Consultancy Period begins January 1, 2027, and ends no later than December 31, 2028, unless extended by mutual agreement.
• · No new compensatory equity grants will be awarded to Griffith after the Effective Date.
• · Griffith will lose all employee benefits (medical, dental, life insurance, bonuses, PTO, stock purchase plan, pension) after the Employment Termination Date.
• · The share repurchase of 300,000 shares must occur on or before June 30, 2026, at the closing market price on the day prior to repurchase.
• · Griffith must execute a General Release and Waiver Agreement as a condition to receiving severance benefits.

17-06-2026

Fiserv, Inc. issued €1.0 billion aggregate principal amount of senior notes in a public offering on June 16, 2026, comprising €500 million of 3.750% Senior Notes due 2030 and €500 million of 4.250% Senior Notes due 2034. The offering is expected to close on June 23, 2026, with customary closing conditions. No period-over-period comparisons or mixed performance metrics are provided in this filing.

• · The offering is conducted under a Registration Statement on Form S-3 (No. 333-277241) filed on February 22, 2024, as amended by Post-Effective Amendment No. 1 on April 24, 2025.
• · The Underwriting Agreement includes customary representations, warranties, indemnification rights, and termination provisions.
• · The notes are registered under the Securities Act of 1933.

17-06-2026

HEICO Corp entered into a Fourth Amendment to its Revolving Credit Agreement on June 11, 2026. The amendment increases the revolving credit facility capacity from $2.0 billion to $2.2 billion and extends the maturity date to June 11, 2031. Concurrently, all subsidiary guarantors were released from their guarantee obligations under the credit facility and related senior notes, reducing the company's contingent liabilities but potentially weakening creditor protections.

• · The amendment modifies the applicable interest rate to be based on the most recently published ratings for HEICO's senior unsecured long-term debt.
• · All subsidiary guarantors were released from guarantee obligations under both the credit facility and the outstanding notes (5.250% due 2028 and 5.350% due 2031).
• · Conditions for effectiveness included receipt of executed counterparts, a board resolution certificate, legal opinions, good standing certificates, and evidence of subsidiary guarantor releases under the senior notes indenture.

17-06-2026

Plains GP Holdings LP (PAGP) through its subsidiary Plains All American Pipeline, L.P. entered into a new $2.7 billion senior unsecured revolving credit facility on June 12, 2026, replacing existing credit agreements. The facility includes a pricing grid tied to the company's debt ratings, with commitment fees ranging from 0.100% to 0.250% and interest margins from 1.000% to 1.750% for Term SOFR loans. The agreement involves a large syndicate of lenders and provides for letters of credit, swing line loans, and potential future increases in commitments.

• · The credit agreement is dated June 12, 2026, and was filed as an 8-K on June 17, 2026.
• · The facility includes a $2.7 billion aggregate commitment with potential for future increases.
• · Pricing is determined by a five-level grid based on S&P and Moody's debt ratings, with a mechanism for split ratings.
• · The agreement includes provisions for Designated Borrowers, extension of maturity date, and increase in commitments.
• · The facility refinances outstanding indebtedness under the Existing Credit Agreement and the Existing PMLP Credit Agreement.
• · The agreement contains a consolidated leverage ratio covenant (Section 7.07) and other negative covenants.
• · The administrative agent is Bank of America, N.A., and the swing line lender is also Bank of America, N.A.

17-06-2026

Plains All American Pipeline, L.P. entered into a new $2.7 billion senior unsecured revolving credit agreement dated June 12, 2026, with Bank of America as administrative agent and a syndicate of lenders. The facility refinances existing indebtedness under prior credit agreements and includes pricing grids tied to the company's debt ratings, with commitment fees ranging from 0.100% to 0.250% and interest margins from 1.000% to 1.750% for Term SOFR loans. The agreement also provides for potential increases in commitments and extensions of maturity dates.

• · The credit agreement includes a swing line loan facility and letter of credit subfacility.
• · The facility is governed by a pricing grid based on S&P and Moody's debt ratings, with five pricing levels.
• · The agreement contains a consolidated leverage ratio covenant (Section 7.07) and negative covenants on liens, indebtedness, and restricted payments.
• · The initial aggregate commitments are $2.7 billion, with provisions for increases under Section 2.16.
• · The maturity date may be extended under Section 2.14 at the company's option with lender consent.
• · The facility refinances outstanding indebtedness under the Existing Credit Agreement and the Existing PMLP Credit Agreement.

17-06-2026

Sleep Number Corporation (SNBR) received a delisting notice from Nasdaq following its Chapter 11 bankruptcy filing on June 12, 2026. Trading of SNBR common stock will be suspended effective June 23, 2026, and the company does not intend to appeal. While the company asserts that the delisting will not affect business operations or the bankruptcy process, investors face significant uncertainty regarding the residual equity value and potential over-the-counter trading viability.

• · Chapter 11 petitions were filed voluntarily on June 12, 2026 in the Southern District of New York.
• · Nasdaq's delisting determination was based on public interest concerns, residual equity interest of common stockholders, and ability to sustain listing compliance.
• · Nasdaq will file a Form 25-NSE with the SEC to complete the delisting process.
• · The company does not expect the delisting to affect business operations or the Chapter 11 Cases.
• · Post-suspension, common stock may be quoted on OTC markets, but no assurance is given about trading, broker-dealer quotes, or an efficient market developing.

17-06-2026

Magnachip Semiconductor Corporation entered into an At Market Issuance Sales Agreement with B. Riley Securities, Inc. on June 17, 2026, allowing the company to sell up to $50,000,000 of its common stock from time to time. The company intends to use net proceeds for general corporate purposes, including investments in strategic growth initiatives and technologies supporting AI data centers and robotics. The filing does not include any period-over-period financial comparisons, so no balanced performance analysis is possible.

• · The Sales Agreement is an at-market issuance facility, not a firm commitment; the company is not obligated to sell any shares.
• · The shelf registration statement (Form S-3, No. 333-296756) was filed on June 12, 2026 and declared effective on June 16, 2026.
• · The Sales Agent (B. Riley Securities) will use commercially reasonable efforts to sell shares based on the company's instructions, including price, time, or size limits.
• · The agreement can be terminated by either party at any time upon written notice.
• · The company's common stock trades on the New York Stock Exchange under the symbol MX.

17-06-2026

Bed Bath & Beyond, Inc. (Parent) has entered into a definitive merger agreement to acquire Fathom Holdings Inc. (Company) through a stock-for-stock merger, with Fathom Merger Sub merging into the Company. The transaction is structured as a tax-free reorganization under Section 368(a) of the Code, with Fathom stockholders receiving shares of Bed Bath & Beyond common stock based on an exchange ratio. The agreement includes voting and support agreements with certain Company directors and officers, and the boards of both companies have approved the transaction as fair and in the best interests of their respective stockholders.

• · The merger is structured as a reverse triangular merger under the NCBCA and Delaware GCL, with Fathom surviving as a wholly owned subsidiary of Bed Bath & Beyond.
• · Each share of Fathom common stock (excluding cancelled shares) will be converted into the right to receive a number of Bed Bath & Beyond common shares equal to the Exchange Ratio, rounded down to the nearest whole share.
• · Fathom shares held as treasury stock or by Bed Bath & Beyond or its subsidiaries will be cancelled without consideration.
• · The closing is conditioned on satisfaction or waiver of conditions in Article 7, and is expected to occur within two business days after conditions are met.
• · The agreement includes a non-solicitation covenant (Section 6.3) restricting Fathom from soliciting alternative acquisition proposals.
• · Termination fees are addressed in Section 8.3, though specific amounts are not disclosed in this excerpt.
• · The exchange ratio is subject to adjustment for stock splits, dividends, or other reclassifications prior to the effective time.

17-06-2026

eXoZymes Inc. closed a $6 million underwritten public offering of common stock and warrants, generating approximately $5.95 million in gross proceeds. The company plans to use the net proceeds for development of NCT, R&D, and general corporate purposes. While the capital raise strengthens its balance sheet, the issuance also dilutes existing shareholders, and the warrants have a potential price reset that could lead to further dilution.

• · Each unit consists of two shares of common stock and one warrant to purchase one additional share.
• · Warrant exercise price is $11.24 per share, exercisable after one year, expiring five years from issuance.
• · Warrants are not listed on any exchange and may be redeemed by the company upon certain conditions.
• · Warrant exercise price may reset to $0.001 if the company sells additional shares at less than $8.99 before June 5, 2027.
• · Offering was made under a shelf registration statement effective January 23, 2026.
• · Prospectus supplement was filed with the SEC on June 8, 2026.

17-06-2026

Allbirds, Inc. has completed its sale of the Allbirds brand and footwear assets, changed its name to Smartbird, Inc., and appointed Nadia Carlsten as president, CEO, and board member to lead its new AI infrastructure strategy. The company increased its convertible financing facility from $50 million to $100 million to strengthen its balance sheet. However, the company is in early stages with no revenue from its new AI business, and the prior Allbirds operations have been divested, creating significant execution risk.

• · The company's Class A common stock continues to trade under ticker 'BIRD' on Nasdaq with unchanged CUSIP.
• · Nadia Carlsten holds a doctorate in engineering from UC Berkeley and bachelor degrees in chemistry and physics from the University of Virginia.
• · Lily Yan Hughes has served as an independent director since October 2025 and has a 30-year track record in corporate governance and capital markets.
• · Annie Mitchell has served as CFO for the past three years and will continue in that role.
• · The company is in active discussions with prospective customers and is currently designing its first cluster deployments, indicating no revenue-generating deployments yet.
• · The inducement RSU award of 1,532,379 RSUs is intended to qualify under Nasdaq Listing Rule 5635(c)(4).

17-06-2026

KOIL Energy Solutions, Inc. announced a major project award for subsea umbilical handling, spooling, and storage services, which will utilize both a newly acquired 3,500-metric-ton mobile offshore carousel and an existing underutilized carousel. The project is expected to be executed in the second half of 2026, followed by long-term storage of the customer's umbilical system. The company secured a new credit facility last month to finance the new asset and support its broader rental equipment investment plan.

• · The new carousel is modular and designed to be assembled on board a vessel, enabling rapid mobilization and redeployment to new project locations in the U.S. and internationally.
• · The work will be performed by KOIL's experienced service team during the second half of 2026.
• · The project includes long-term storage of the customer's umbilical system after the handling and spooling work.
• · The new credit facility was secured last month (prior to June 11, 2026) to finance the new asset and support the rental equipment investment plan.

17-06-2026

Fathom Holdings Inc. (FTHM) announced a definitive merger agreement to be acquired by Bed Bath & Beyond (BBBY) in an all-stock transaction implying an equity value of approximately $53.38 million. The exchange ratio is 0.2236 BBBY shares per FTHM share. Additionally, Adam Rothstein was appointed Interim CEO and Daniel Weinmann as CFO. The transaction is expected to close in H2 2026, subject to stockholder and regulatory approvals.

• · Exchange ratio: 0.2236 shares of Bed Bath & Beyond common stock for each Fathom share.
• · Transaction expected to close in the second half of 2026.
• · Adam Rothstein appointed Interim CEO and Daniel Weinmann appointed CFO, effective immediately.
• · Fathom's brands include Fathom Realty, Encompass Lending, intelliAgent, Real Results, and Verus Title.

17-06-2026

Playboy, Inc. reported 2025 revenue of $120.9M and highlighted five consecutive quarters of positive Adjusted EBITDA, with Adjusted EBITDA doubling YoY in Q1 2026. The company entered a strategic licensing joint venture with UTG, selling a 50% interest in its China licensing business for $45M in cash plus $67M in guaranteed minimum annual distributions over 8 years and $10M in brand support payments over 3 years, with $52M earmarked for debt reduction. However, the company still carries $145M in gross debt (down from $218M in Q3 2024) and faces risks including high concentration of licensing revenue from a small number of licensees and reliance on forward-looking projections.

• · Insider holdings represent 49.6% of shares outstanding.
• · Headquarters relocated to Miami Beach, FL as announced on August 13, 2025.
• · The company has a dual audience strategy: men drive engagement and subscriptions; women participate as creators and consumers of licensed products.
• · The UTG joint venture includes possible profit share upside beyond the $122M in guaranteed minimum payments.
• · The company's business model is described as asset-light, with licensing, media, and hospitality generating high-margin revenue.
• · The company's revenue is highly concentrated from a small number of licensees (risk factor).
• · The company has simplified operations through divestitures and outsourcing.

17-06-2026

AstroNova, Inc. (ALOT) has entered into a definitive agreement to be acquired by Arcline Investment Management in an all-cash transaction valued at $29.00 per share, representing a total enterprise value of approximately $272 million. The per share price reflects a 209% premium over the unaffected closing price on April 6, 2026, and a 120% premium over the 90-day VWAP ending June 16, 2026. The transaction, unanimously approved by AstroNova's Board, is expected to close in Q3 2026, subject to stockholder and regulatory approvals.

• · The transaction follows a previously announced review of strategic alternatives intended to maximize shareholder value.
• · AstroNova will become a privately held company upon completion.
• · Arcline is a growth-oriented private equity firm with over $30 billion in assets under management.
• · The acquisition is expected to close in the third quarter of 2026, subject to stockholder approval and regulatory approvals.
• · Rockefeller Capital Management served as exclusive financial advisor to AstroNova; Mesirow served as exclusive financial advisor to Arcline.

17-06-2026

SharonAI Holdings, Inc. announced an oversubscribed US$1.6 billion strategic financing to accelerate expansion of AI Factories across Australia and Asia-Pacific. The transaction includes a US$900 million private placement of common stock and pre-funded warrants, and US$700 million in 4.75% Convertible Senior Notes due 2032, anchored by Situational Awareness and Oaktree. Proceeds will support a six-year compute collaboration with NVIDIA to deploy up to 40,000 Grace Blackwell GB300 GPUs, with total AI Factory capacity expanded to 132MW (102MW contracted) and over 55,000 NVIDIA GPUs expected by mid-2027.

• · The private placement is expected to close on or about June 22, 2026, subject to customary closing conditions.
• · The Convertible Senior Notes will mature on June 15, 2032, unless earlier converted, redeemed or repurchased.
• · Interest on the Notes is payable semi-annually in arrears in cash.
• · The securities have not been registered under the Securities Act of 1933 and may not be offered or sold in the U.S. absent registration or exemption.
• · The Company has agreed to file a resale registration statement with the SEC.
• · Goldman Sachs & Co. LLC is serving as lead placement agent; Lucid Capital Markets as placement agent; Macquarie Capital as financial advisor; Sheppard Mullin Richter & Hampon as legal advisor.

17-06-2026

Lakewood-Amedex Biotherapeutics Inc. filed an 8-K on June 17, 2026, reporting a modification of security holder rights via a Certificate of Change filed with the Nevada Secretary of State on June 15, 2026. The filing does not disclose specific financial figures or operational metrics, making it a procedural corporate action.

• · Filing type: 8-K
• · Items covered: 3.03 (Security Holder Rights Modification), 5.03 (Amendments to Articles of Incorporation or Bylaws), 9.01 (Financial Statements and Exhibits)
• · Certificate of Change filed with Nevada Secretary of State on June 15, 2026
• · Business Number: E49492572025-8
• · Filing Number: 20265815078
• · Number of pages in exhibit: 1

17-06-2026

Potomac Electric Power Company (Pepco) issued $300 million in aggregate principal amount of First Mortgage Bonds across three series on June 17, 2026, pursuant to a Bond Purchase Agreement entered into on March 19, 2026. The proceeds will be used to repay existing indebtedness and for general corporate purposes. The offering was conducted as a private placement exempt from registration under Section 4(a)(2) of the Securities Act.

• · The Bond Purchase Agreement was entered into on March 19, 2026, and the closing occurred on June 17, 2026.
• · The bonds were issued under a Mortgage and Deed of Trust dated July 1, 1936, as supplemented by a Supplemental Indenture dated March 1, 2026.
• · The offering was made in reliance on the Section 4(a)(2) exemption from registration.
• · The filing includes forward-looking statements and risk factors related to regulatory actions, environmental liabilities, cybersecurity, and other uncertainties.

17-06-2026

Hyundai Auto Receivables Trust 2026-B issued approximately $1.5B in asset-backed notes on June 17, 2026, backed by auto loan receivables, as part of a securitization transaction. The filing documents the entry into several material definitive agreements, including the Receivables Purchase Agreement, Sale and Servicing Agreement, Indenture, and related contracts, with Hyundai Capital America acting as sponsor, seller, and servicer. No period-over-period comparisons or performance metrics are provided in this filing.

• · The trust was created under an Amended and Restated Trust Agreement dated June 17, 2026, with U.S. Bank Trust National Association as Owner Trustee.
• · Clayton Fixed Income Services LLC was appointed as asset representations reviewer under an Asset Representations Review Agreement.
• · The transaction was registered under a Form SF-3 shelf registration statement (File No. 333-284087).
• · Securities were issued in seven tranches (Class A-1 through C), with no exchange listing (trading symbol N/A on all exchanges).

17-06-2026

Liberty Star Uranium & Metals Corp. entered into a Securities Purchase Agreement with 1800 Diagonal Lending LLC on June 15, 2026, issuing a convertible promissory note with an aggregate principal amount of $73,700. The note bears 8% interest, includes a 10% Original Issue Discount, and matures on March 15, 2027. The outstanding principal and accrued interest are convertible into common stock.

• · The note was issued effective June 11, 2026, and matures on March 15, 2027.
• · The filing includes Exhibits 3.85 (Convertible Promissory Note) and 3.86 (Securities Purchase Agreement).
• · The company's common stock trades on OTCQB under symbol LBSR.